DiscoverHeart MattersAssessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials
Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials

Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials

Update: 2023-06-26
Share

Description

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA


Guest: Alan S. Brown, MD, FACC, FAHA, FNLA




Both clinical trials for lowering Lp(a) had patients with established atherosclerotic cardiovascular disease (ASCVD). Join in for a further discussion on important updates presented at the 2023 National Lipid Association Meeting with Dr. Mary Katherine Cheeley and fellow ReachMD host, Dr. Alan Brown, Past President of the National Lipid Association.

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials

Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials